Summary
58 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 11 EUR is left as net profit.
- It has raised its dividend 5 years in a row and pays out only 42% of profit.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 3.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 27.6 EUR for 1 EUR of yearly profit. Over the last five years it was 24.2 EUR on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 2.9% a year over 5 years. Over the last 3 years it fell by 3.0% a year. For the next fiscal year analysts expect revenue to grow by 8.4%. Earnings per share fell by 9.1% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 41 EUR
- Research and development 13 EUR
- Sales and administration 27 EUR
- Taxes and other 8.3 EUR
- Net profit 11 EUR
Net profit, industry median (Drug Manufacturers - Specialty & Generic) 10 EUR
Out of every 100 EUR of revenue, 11 EUR is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.53%
- Paid out of profit
- 42%
- Raised in a row
- 5 years
You receive $0.51 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.